AI-generated analysis. Always verify with the original filing.
Pulse Biosciences, Inc. entered into an equity distribution agreement on February 19, 2026, and terminated a prior at-the-market sales agreement on February 18, 2026. The new agreement is documented as Exhibit 1.1.
Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement. On February 19, 2026, Pulse Biosciences, Inc. (the “Company”) entered into an equity distribution agreement (the “Sa
Termination of a Material Definitive Agreement. Prior to the Company’s entry into the Sales Agreement, on February 18, 2026, the Company terminated its at-the-m
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 1.1 Equity Distribution Agreement, dated February 19, 2026, by and between Pulse Bios